A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥16 to 80 Years Old) With Partial Onset Seizures
A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥16 to 80 Years Old) With Partial Onset Seizures
This study will evaluate the efficacy and safety of brivaracetam at doses of 100 and 200mg/day compared to placebo as adjunctive treatment in adult focal epilepsy subjects with partial onset seizures not fully controlled despite current treatment with 1 or 2 concomitant antiepileptic drugs.
Inclusion Criteria:
Exclusion Criteria:
Hechteleksel, Belgium
Riberao Preto, Brazil
Blagoevrad, Bulgaria
Ostrava Poruba, Czechia
Kehl-Kork, Germany
Hyderabad, Andhra Pradesh, India
Daugapils, Latvia
Taoyuan Hsien, Taiwan
Cornwall, United Kingdom